BioCentury | Jun 5, 2014
Strategy

Sanford-Burnham goes fourth

...olmesartan/hydrochlorothiazide Fixed-dose combination of olmesartan and hydrochlorothiazide, a diuretic Marketed for hypertension Not applicable Tribenzor/Sevikar HCT olmesartan/amlodipine/hydrochlorothiazide...
BioCentury | Jul 15, 2013
Clinical News

Azor/Sevikar olmesartan/amlodipine regulatory update

...diuretic; Azor, a fixed-dose combination of olmesartan and amlodipine, a dihydropyridine calcium channel blocker; and Tribenzor...
.../ Sevikar olmesartan/amlodipine; Benicar /Olmetec olmesartan; Benicar HCT olmesartan/ hydrochlorothiazide; Tribenzor / Sevikar HCT olmesartan/amlodipine/hydrochlorothiazide ( CS-8635...
BioCentury | Dec 5, 2011
Company News

Daiichi Sankyo sales and marketing update

...Daiichi's Daiichi Sankyo UK unit launched Sevikar HCT in the U.K. to manage hypertension. The fixed-dose combination...
...a dihydropyridine calcium channel blocker, and hydrochlorothiazide, a diuretic, is approved in the U.S. as Tribenzor...
BioCentury | Oct 17, 2011
Clinical News

Sevikar HCT regulatory update

...The Scottish Medicines Consortium recommended the use of Sevikar HCT from Daiichi Sankyo on the National Health...
...approved indication. The drug is approved in the U.S. as Tribenzor to lower blood pressure. Sevikar HCT...
...Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Sevikar HCT ( Tribenzor - U.S.) olmesartan/amlodipine/hydrochlorothiazide ( CS-8635...
BioCentury | Aug 2, 2010
Clinical News

Tribenzor olmesartan/amlodipine/hydrochlorothiazide regulatory update

...Product: Tribenzor olmesartan/amlodipine/hydrochlorothiazide ( CS-8635 ) Business: Cardiovascular FDA approved an NDA from Daiichi for Tribenzor...
...includes a black box warning stating that patients should discontinue use if they become pregnant. Tribenzor...
BioCentury | May 10, 2010
Clinical News

Olmesartan/amlodipine/hydrochlorothiazide: Phase III data

...of the Phase III TRINITY trial in 2,492 patients with moderate-to-severe hypertension showed that the olmesartan/amlodipine/hydrochlorothiazide...
...approved for the indication. Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Product: Olmesartan/amlodipine/hydrochlorothiazide ( CS-8635...
BioCentury | May 4, 2010
Clinical News

Daiichi reports Phase III hypertension data

...Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) said olmesartan/amlodipine/hydrochlorothiazide triple combination therapy met the primary endpoint of...
Items per page:
1 - 7 of 7